Not Yet RecruitingNCT07685964
Pregnenolone for Addiction and Depression
Medication studyAges 18–50United States
Understand this study
Who could participate?
Listed age limits: 18 years to 50 years.
- Listed locations
- Dallas and 1 more locationSee all locations and recruitment
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: September 2026
- Recruitment status
- Not Yet Recruiting
- Enrollment listed in the registry
- 20
- Sponsor
- University of Texas Southwestern Medical Center
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- From 18 Years to 50 Years
- Official registry ID
- NCT07685964
- Official title
Show the full official title
Advancing Pregnenolone as a Novel Therapy for Co-Occurring Cannabis Use Disorder and Depression
Recruitment & locations
Not yet recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Dallas · Richardson
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Texas Southwestern Medical Center, a university.
Does this study involve medication?
Yes. The study involves medication, including Pregnenolone.
Who can participate?
Listed age limits: 18 years to 50 years.
Is this study still recruiting?
The registry lists this study as not yet recruiting.
